April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Erman Akkus: Our study on SGLT2 and papillary RCC
Feb 10, 2025, 15:21

Erman Akkus: Our study on SGLT2 and papillary RCC

Erman Akkus, Medical Oncology Fellow at Ankara University, shared an article on X:

“Our study on SGLT2 and papillary RCC has been published!

SGLT2 inhibitors dramatically changed the treatment of diabetes, heart failure and chronic kidney disease.

SGLT2 is selectively expressed in kidney.

Our study suggest SGLT2 may be a potential biomarker and target in papillary RCC, calling for further studies.”

Erman Akkus: Our study on SGLT2 and papillary RCC

Sodium-Glucose Cotransporter 2 (SGLT2) as a Potential Biomarker and Target in Papillary Renal Cell Carcinoma.

Authors: Erman Akkus, et al.

 Erman Akkus: Our study on SGLT2 and papillary RCC